Specific hybridoma cell line and monocolonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens
US4873313A · kind A · utility
18Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 1985 |
| Grant date | Oct 10, 1989 |
| Priority date | — |
| Expiry date | Apr 18, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A specific hybridoma cell line produces monoclonal antibodies which are effective in detecting carcinoembryonic antigens (CEA). The specific hydribome line and monoclonal antibodes are designated as T84.66-A3.1-H11. The monoclonal antibodies are preferably applied to tissues and fluids to detect the degree of binding of such monoclonal antibodies to such carcinoembryonic antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.